cephalexin

Product NDC
50090-6445
11-digit product format
500906445
Labeler code
50090
Product ID
50090-6445_77c698ed-fa40-46d8-8ea2-b75ab8f1bfad
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cephalexin
Dosage form
FOR SUSPENSION
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA065234
Marketing category
ANDA
Marketing start
2017-09-06
Substance
CEPHALEXIN
Active strength
250 mg/5mL
Pharmacologic classes
Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A065234-001CEPHALEXINCEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17
A065234-002CEPHALEXINCEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A065234-001AB
A065234-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17caaa826d4ba7…
2026-08-18 06:07:402026-07A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17011fe1cb6892…
2026-02-19 14:30 UTC2026-02A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-1731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-1731067a03dcf5…
2025-08-23 18:47 UTC2025-08A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-176a471c1ec25d…
2025-08-23 18:47 UTC2025-08A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-176a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-1703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-1703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-172680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-172680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-175bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-175bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17d06236e962d9…
2024-10-29 15:01 UTC2024-10A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-1779d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-1779d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-171e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-171e350fbaab3a…
2024-05-31 18:47 UTC2024-05A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-178072bd15b7f6…
2024-05-31 18:47 UTC2024-05A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-178072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-175c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-175c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-175d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-175d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-174b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-174b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-1774a2ff9319b5…
2019-12-13 00:20 UTC2019-12A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-1774a2ff9319b5…
2022-03-09 01:35 UTC2022-03A065234-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A065234-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALAB2005-08-17bb7c543d1eb4…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A065234-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A065234-002AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A065234-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A065234-002AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A065234-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A065234-002AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A065234-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A065234-002AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A065234-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A065234-002AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A065234-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A065234-002AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A065234-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A065234-002AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A065234-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A065234-002AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A065234-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A065234-002AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A065234-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A065234-002AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A065234-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A065234-002AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A065234-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A065234-002AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A065234-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A065234-002AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A065234-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A065234-002AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A065234-001AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05A065234-002AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A065234-001AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A065234-002AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A065234-001AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A065234-002AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A065234-001AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A065234-002AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A065234-001AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A065234-002AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A065234-001AB1bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A065234-002AB1bb7c543d1eb4…

Additional Listing Data#

Finished product
Yes
Brand name base
cephalexin
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CEPHALEXIN250 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
OBN7UDS42YInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
309113Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
0a24b6e5-6f13-44b4-93f4-47c86945cad2Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dfa3f520-409c-432e-b6d3-9250d468c772Product name120250401
c6f86816-7da6-43ea-8c25-ac9758311cc5Product name120220118
64bb7f1a-2c2e-4741-8301-dbfeda7239f6Product name120190628
252e11b6-1a9a-4283-a242-df2c129c496dProduct name320170717
398aa563-bb78-fe0f-46a8-757c40ef28bfProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50090-6445-0cephalexin100 mL in 1 BOTTLEFOR SUSPENSION1001

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-6445-0ML - Milliliter50090-6445a5b4371a-ff91-48dd-9c77-c85ab28436d012023-06-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-6445CEPHALEXIN FOR SUSPENSION [A-S MEDICATION SOLUTIONS]1Current NDC, 1 package rows20230427_0a24b6e5-6f13-44b4-93f4-47c86945cad2.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
cephalexinCEPHALEXINLupin Pharmaceuticals, Inc.25ef498a-7a7e-4543-a544-b9d0e99f9cd92026-06-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 065234
application number: ANDA065234
cephalexinCEPHALEXINPreferred Pharmaceuticals Inc.553485f8-890d-4929-a6bb-905221cf411d2026-03-25Warnings, Adverse reactionsExact identifier
application applno (ANDA): 065234
application number: ANDA065234
cephalexinCEPHALEXINNuCare Pharmaceuticals,Inc.141bd050-5dfc-68fa-e063-6394a90a6d862024-03-20Warnings, Adverse reactionsExact identifier
application applno (ANDA): 065234
application number: ANDA065234
cephalexinCEPHALEXINA-S Medication Solutionsd31da5be-c939-4aa0-adb8-b26a1396b2282024-02-22Warnings, Adverse reactionsExact identifier
application applno (ANDA): 065234
application number: ANDA065234
cephalexinCEPHALEXINProficient Rx LP829244bd-93da-4a5a-a257-890cfec4c06d2023-12-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 065234
application number: ANDA065234
cephalexinCEPHALEXINA-S Medication Solutions0a24b6e5-6f13-44b4-93f4-47c86945cad22023-04-26Warnings, Adverse reactionsExact identifier
application applno (ANDA): 065234
application number: ANDA065234
ndc (product): 50090-6445

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
309113cephalexin 250 MG in 5 mL Oral SuspensionPSN0a24b6e5-6f13-44b4-93f4-47c86945cad21
309113cephalexin 50 MG/ML Oral SuspensionSCD0a24b6e5-6f13-44b4-93f4-47c86945cad21
309113cefalexin 50 MG/ML Oral SuspensionSY0a24b6e5-6f13-44b4-93f4-47c86945cad21
309113cephalexin 250 MG per 5 ML Oral SuspensionSY0a24b6e5-6f13-44b4-93f4-47c86945cad21

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
50090-6445-050090644500100 mL in 1 BOTTLE (50090-6445-0) 100 ml2023-04-20NoNoCurrent